Nephrology
Conference Coverage
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss.
Livin' on the MDedge
The most important meal of the day, with extra zinc
Plus, livers live the hop life and babies get scared by their microbiomes.
From the Journals
Third COVID-19 vaccine dose helped some transplant recipients
All of those with low titers before the third dose had high titers after receiving the extra shot, in case series.
Livin' on the MDedge
Gene therapy is bad business, and hugging chickens is just … bad
Plus, brains that can type and geologists who conduct kidney research.
Conference Coverage
Ultrasound renal denervation drops BP in patients on triple therapy
Feature
Finerenone scores second pivotal-trial success in patients with diabetic kidney disease
News
FDA approves dapagliflozin (Farxiga) for chronic kidney disease
Based on results of the DAPA-CKD trial, the FDA has granted approval for the diabetes drug in patients with CKD at risk for disease progression....
Latest News
Pregnancy increases risk for symptomatic kidney stones
“We suspected the risk of a kidney stone event would be high during pregnancy, but we were surprised that the risk remained high for up to a year...
Conference Coverage
Half of patients in hospital for COVID-19 get acute kidney injury
It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening...
Feature
Patient benefits justify price of new lupus nephritis drugs
Prices of two new drugs approved by the FDA for lupus nephritis are in reasonable alignment with their estimated benefits for patients with the...
News
Deaths tied to reprocessed urologic endoscopes, FDA warns
The FDA hasn’t concluded that any specific manufacturer or brand of these devices is associated with higher risks than others.